Carcinoma, Ovarian Epithelial: all 1,619 studies
Page 14 of 17. Open to participants first (245), then studies with results posted, then the rest; newest registration first within each.
- YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving ChemotherapyTerminatedNCT00899093
- Identifying Genetic Markers That Predict Response to Paclitaxel in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal CancerTerminatedNCT00897806
- Collecting Tumor Samples From Patients With Gynecological TumorsCompletedNCT00897442
- Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerStatus unknownNCT00897039
- Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous TherapyCompletedNCT00892736Phase 1
- Intraperitoneal (IP) Cisplatin Given With Paclitaxel to Treat Epithelial Ovarian CancerTerminatedNCT00889733Phase 1/2
- A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)CompletedNCT00889382Phase 1/2
- Paclitaxel-Loaded Polymeric Micelle and Carboplatin as First-Line Therapy in Treating Patients With Advanced Ovarian CancerStatus unknownNCT00886717Phase 1/2
- Assessment of Screening Modalities for Gynecologic CancersCompletedNCT00879840
- Determine MTD, Evaluate Efficacy and Safety of Genexol®-PM Plus Carboplatin With Advanced Ovarian CancerCompletedNCT00877253Phase 1
- Panitumumab and Pegylated Liposomal Doxorubicin for Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-typeCompletedNCT00861120Phase 2
- Yoga in Relieving Fatigue in Patients Undergoing Chemotherapy for Ovarian CancerTerminatedNCT00856453Not applicable
- Thymidine Kinase 1 in Risk Assessment for Hereditary Breast /Ovarian CancerStatus unknownNCT00855998
- Screening and Identification of Ovarian CancersStatus unknownNCT00854399Not applicable
- The Role of Regulatory T Cell in Ovarian Cancer: Focus on Relationship Between Clinical Prognosis and Regulatory T Cell ExpressionStatus unknownNCT00854282Not applicable
- Early Post-Operative Enteral Feeding in Patients With Advanced Epithelial Ovarian CancerCompletedNCT00850772Phase 3
- Pharmacokinetic Study of Avastin and Doxil in Ovarian CancerCompletedNCT00846612Phase 1
- p53 Synthetic Long Peptides Vaccine With Cyclophosphamide for Ovarian CancerCompletedNCT00844506Phase 2
- Azacitidine With Carboplatin and Paclitaxel for Newly Diagnosed Ovarian CancerWithdrawnNCT00842582Phase 1
- Two Different Schedules of Carboplatin, Paclitaxel, Gemcitabine, and Surgery in Treating Patients With Newly Diagnosed Stage IIIC or Stage IV Primary Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerStatus unknownNCT00838656Phase 2
- A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian CancerCompletedNCT00831636Phase 1/2
- Attitudes About Childbearing And Fertility With Inherited Breast And Ovarian Cancer Syndromes (HBOC)CompletedNCT00829959
- Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal CavityCompletedNCT00825201Phase 1
- A Phase 1 Study of the Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian CancerCompletedNCT00816764Phase 1
- Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerCompletedNCT00814086Phase 1
- Cost Utility Analysis in Recurrent Ovarian CancerWithdrawnNCT00813254
- Palliative Care During Intraperitoneal Chemotherapy in Patients With Ovarian CancerCompletedNCT00804258
- FR in Stored PlasmaCompletedNCT00787514
- A Phase I/II Study of Paclitaxel Plus Carboplatin Plus Vorinostat in Recurrent Ovarian CancerStatus unknownNCT00772798Phase 2
- AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CRCompletedNCT00770536Phase 1
- Topotecan Liposomes Injection for Small Cell Lung Cancer (SCLC), Ovarian Cancer and Other Advanced Solid TumorsCompletedNCT00765973Phase 1
- Early Detection of Ovarian Cancer: GC/FT-ICR Mass Spectrometry and Canine OlfactionCompletedNCT00757952
- Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United KingdomStatus unknownNCT00757263
- Efficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients.WithdrawnNCT00753740Phase 2
- Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian CarcinomasCompletedNCT00750386Phase 1/2
- Carboplatin With or Without Decitabine in Treating Patients With Progressive, Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerTerminatedNCT00748527Phase 2
- Bevacizumab and Carboplatin for Patients With Ovarian CancerCompletedNCT00744718Phase 2
- Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer RiskCompletedNCT00735150
- Platinum Resistant Ovarian Cancer Evaluation of Doxil and Vintafolide (MK-8109, EC145) Combination Therapy (8109-009, EC-FV-04)CompletedNCT00722592Phase 2
- Green Tea Intake for the Maintenance of Complete Remission in Women With Advanced Ovarian CarcinomaCompletedNCT00721890Phase 2
- Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerStatus unknownNCT00719303Phase 3
- Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized StudyStatus unknownNCT00715286Phase 3
- The Effect of TRA-8 on Ovarian Cancer TissueCompletedNCT00711932
- Ovarian Dendritic Cell Vaccine TrialStatus unknownNCT00703105Phase 2
- Vaccine Therapy and OPT-821 or OPT-821 Alone in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer in Complete RemissionWithdrawnNCT00693342Phase 3
- Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their CaregiversCompletedNCT00684801
- Single Arm Study of BSI-201 in Patients With BRCA-1 or BRCA-2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00677079Phase 2
- Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian CancerCompletedNCT00664781Phase 2
- Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian CancerStatus unknownNCT00660842Phase 3
- Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian CancerStatus unknownNCT00660101Phase 1/2
- Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of ProgressionWithdrawnNCT00659399Phase 1
- Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian CancerCompletedNCT00659178Phase 1
- Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free IntervalStatus unknownNCT00657878Phase 3
- CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based ChemotherapyTerminatedNCT00653952Phase 3
- Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal CancerCompletedNCT00652691Phase 1
- Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian CancerCompletedNCT00648102Phase 1
- Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin)CompletedNCT00635193Phase 1/2
- Glycan Analysis in Diagnosing Cancer in Women With Ovarian Epithelial Cancer and in Healthy Female ParticipantsCompletedNCT00628654
- Contrast-Enhanced Ultrasonography in Diagnosing Early-Stage Ovarian Cancer in Patients With an Adnexal Mass Undergoing Surgery to Remove the OvaryCompletedNCT00626873Phase 1
- Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer.CompletedNCT00620243Early Phase 1
- Phase 2 Study of Twice Weekly VELCADE and CAELYX in Patients With Ovarian Cancer Failing Platinum Containing RegimensWithdrawnNCT00610792Phase 2
- Telemedicine vs. Face-to-Face Cancer Genetic CounselingCompletedNCT00609505Not applicable
- A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial CancerCompletedNCT00607607Phase 2
- Sexual Functioning After Primary Treatment of Ovarian CancerTerminatedNCT00596544
- Women Surviving Ovarian CancerCompletedNCT00596349
- A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian CancerCompletedNCT00587093Not applicable
- Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian CancerCompletedNCT00563836Phase 2
- Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian CancerWithdrawnNCT00562185Phase 1/2
- Safety Study of a Genetically Modified Adenovirus in Ovarian Cancer PatientsCompletedNCT00562003Phase 1
- Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line ChemotherapyWithdrawnNCT00551265Not applicable
- Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerCompletedNCT00550784Phase 1
- Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase InhibitorCompletedNCT00543049Phase 2
- Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO)CompletedNCT00538603Not applicable
- Hydralazine Valproate for Ovarian CancerStatus unknownNCT00533299Phase 3
- An RCT of Concurrent and Maintenance Cediranib in Women With Platinum-sensitive Relapsed Ovarian CancerStatus unknownNCT00532194Phase 3
- NYU Ovarian Cancer Early Detection Program Blood and GeneticsTerminatedNCT00531778
- Microvascular Ultrasonographic Imaging for the Detection of Early Stage Epithelial Ovarian CarcinomaCompletedNCT00531570
- Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian CancerCompletedNCT00529022Phase 1
- Adjuvant Whole Abdominal Intensity Modulated Radiotherapy (IMRT) for High Risk Stage FIGO III Patients With Ovarian CancerStatus unknownNCT00527631Phase 1
- Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual FunctionCompletedNCT00525460
- Efficacy Study of Recombinant Interleukin-21 in the Treatment of Ovarian CancerCompletedNCT00523380Phase 2
- Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This QuestionnaireCompletedNCT00517621Phase 2
- A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal CancerTerminatedNCT00516841Phase 2
- Quality of Life Associated With a Low-Risk Screening Program for Ovarian CancerStatus unknownNCT00511641
- Chemotherapy-Related Toxicities In Ovarian Cancer PatientsCompletedNCT00508378
- Role of Spirituality in Coping and Surviving With Ovarian Cancer, Primary Peritoneal or Fallopian Tube CancerStatus unknownNCT00499512
- Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian CancerCompletedNCT00490711Phase 2
- Advanced Ovarian Cancer and Sexuality Phase 1CompletedNCT00488202
- Ovarian Cancer Patient Questionnaire on Genetic TestingCompletedNCT00486707
- Platinum-Resistant, Recurrent Epithelial Ovarian CancerWithdrawnNCT00484666
- Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Advanced or Metastatic Ovarian CancerCompletedNCT00484432Phase 2
- Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerCompletedNCT00483782Phase 3
- Dendritic Cell Vaccine for High Risk Ovarian Cancer PatientsCompletedNCT00478452Phase 1
- Ovarian Cancer and Immune Response to Flu VaccineCompletedNCT00478387
- Economic Outcomes in Patients With Stage III Ovarian Cancer Receiving Paclitaxel and Cisplatin on Clinical Trial GOG-172WithdrawnNCT00477867Not applicable
- Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian CancerCompletedNCT00477282Phase 3
- A Phase I Study of Intraperitoneal Hyperthermic DocetaxelCompletedNCT00474669Phase 1
- Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian CancerCompletedNCT00466986Phase 2
- MRI in Staging Ovarian Cancer Using MRI Contrast AgentStatus unknownNCT00463996
- Depression and Interleukin-6 Production in Patients With Ovarian Epithelial CancerWithdrawnNCT00460200